google.com, pub-8701563775261122, DIRECT, f08c47fec0942fa0
UK

Superbugs could kill millions more and cost $2tn a year by 2050, models show | Antibiotics

Super insects can cause millions of people to die worldwide and cost the global economy slightly below $ 2 million a year until 2050.

A study financed by the British government shows that increasing antimicrobial resistance rates (AMR) can lead to globalization without harmonious action. Annual GDP losses Century in the next track.

Research, Global Development Center Thinktank asked the United States, the UK and the EU economies will be among the most difficult hits and the last swingeing aid cuts were self -defeated.

On Thursday, the United Kingdom government Balkuz Fund for Fleming FundAs part of wider aid cuts, it struggles with AMR in low and medium -income countries. The Trump administration confirmed $ 9 billion deductions according to the foreign aid budget, and a number of European countries have reduced expenditures for overseas aid.

Anthony McDonnell, a chief author and a policy member at the Global Development Center, said: “When we conducted our research on the economic effects of antimicrobial resistance, resistance rates were foreseen to continue to follow historical trends.

“However, sudden interruptions for the US official development aid, which reduced aid expenditures by approximately 80%, announced aid deductions between 0.5% and 0.3% of 0.3% of gross national income between 0.3%, and the significant decreases made by France, Germany and others can increase resistance rates in accordance with the most pessimistic scenario in our research.

“Even countries that are successful in controlling AMR rates cannot afford to complain. Unless AMR programs are protected from help deductions, worldwide resistance rates will probably increase in accordance with the worst affected countries.

“This will cause millions of people around the world, including G7 countries. Investing for treatment for bacterial infections will now save lives and deliver billions of long -term economic returns.”

The research calculated the economic and health burden of antibiotic resistance for 122 countries, and in this pessimistic scenario, GDP losses in China until 2050 can reach $ 722 billion a year, the EU is $ 187 billion, Japan is $ 65.7 billion and the UK $ 58 $ 58.

Accordingly Health Metriks and Evaluation Institute (IHME) is expected to increase by 60% of deaths from AMR, 60%, 1.34 million people in the US and 184,000 people in the UK are expected to die from antibiotic resistant insects, while the number of patients who are seriously ill from drug -resistant bacteria is expected to skip.

Super insects increase the number of hospital admission and lead to longer and more intense hospital accommodation, more expensive second -step treatments and more complex maintenance, ie resistant infections are roughly twice as expensive than those of antibiotics.

The study estimated that the global health costs of AMR treatment may increase slightly below $ 176 billion per year, while the UK would rise from $ 900 million to $ 3.7 billion in the United Kingdom and to $ 57 billion in the USA from $ 15.5 billion.

In the study, higher resistant insect ratios would shrink the UK, EU and US labor by 0.8%, 0.6% and 0.4%, respectively.

However, if countries invest more in the fight against super insects-increasing access to new antibiotics and high-quality treatment of these infections-the EU economy would grow 156.2 billion dollars per year and the UK would grow by 2050 dollars (£ 9.3 billion).

Responding to the findings. Mohsen Naghavi said, Professor of Health Metriks in Ihme said: “Today, the threat of AMR is increasing, and the drugs we can now access now without immediately action from all stakeholders may cause potentially fatal.”

This will enable the US, Europe and the UK governments that policy changes, the development of new drugs and that everyone understands that antibiotics are ineffective against viruses.

The UK Government Spokesman: “Our 10 -year health plan recognizes antimicrobial resistance (AMR) as a major threat and undertakes to urgently address its spread, including new vaccines.

“We have made significant progress – in meat to reduce the use of antibiotics and to promote the development of new treatments, we lead a first subscription model. In addition, we continue to work closely with international partners to influence global efforts to limit the spread of AMR.”

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button